INBX CIK: 2007919

Inhibrx Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
billions USD
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY23 to FY25
billions USD
FY23:
−0.22
FY24:
−0.33
FY25:
−0.14
(positive)
Change from FY24 to FY25
billions USD
FY23:
–
FY24:
−0.32
FY25:
−0.13
(positive)
Change from FY23 to FY25
billions USD
FY23:
−0.24
FY24:
1.69
FY25:
−0.14
(positive)
Change from FY23 to FY25
billions USD
FY23:
−0.24
FY24:
1.69
FY25:
−0.14

All amounts in billions USD Data sources:SEC EDGARTwelve Data